Principal
Dark Horse Consulting Group
Walnut Creek, California
Brent is a Principal at Dark Horse Consulting Group, where his focus includes supporting clients developing gene-edited therapies, particularly in the areas of analytical development and CMC strategy. Prior to Dark Horse, Brent has led Process and Analytical Development at companies including Vor Biopharma and CRISPR Therapeutics, and his experience includes supporting early development of the approved CRISPR-edited product, Casgevy.
Disclosure information not submitted.